The role of corticotropin-releasing hormone in the regulation of energy balance

Current Opinion in Endocrinology and Diabetes

Volumn 6, Issue 1, 1999, Pages 10-18

  Richard, Denis ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; GLUCOCORTICOID; INSULIN; LEPTIN; MESSENGER RNA; SAUVAGINE; UROCORTIN; UROTENSIN I;

ANOREXIA; ENERGY BALANCE; FOOD DEPRIVATION; FOOD INTAKE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; INSULIN RELEASE; NONHUMAN; OBESITY; REVIEW; THERMOGENESIS;

EID: 0032976907     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199902000-00003     Document Type: Review

References (84)

1. Cusin I, Rohner-Jeanrenaud F: Loop system between neuropeptide Y and leptin: Alteration in rodent obesity syndromes. M S Med Sci 1998, 14:907-913. This paper is an excellent review that summarizes the relationship between leptin, neuropetide Y, and other neuropeptides that are likely involved in the regulation of energy balance.
2. Mountjoy KG, Wong J: Obesity, diabetes and functions for proopiome-lanocortin-derived peptides. Mol Cell Endocrinol 1997, 128:171-177.
3. Richard D: Involvement of corticotropin-releasing factor in the control of food intake and energy expenditure. Ann NY Acad Sci 1993, 697:155-172.
4. Sawchenko PE, Swanson LW: Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed Proc 1985, 44:221-227.
5. Koob GF: The behavioral neuroendocrinology of corticotropin-releasing factor, growth hormone-releasing factor, somatostatin, and gonadotropin-releasing hormone. In Neuroendocrinology, Edited by Nemeroff CB. Boca Raton: CRC Press; 1992:353-364.
6. Brown MR, Fisher LA: Regulation of the autonomic nervous system by corticotropin-releasing factor. In Corticotropin-releasing factor: Basic and clinical studies of a neuropeptide, Edited by De Souza EB, Nemeroff CB. Boca Raton; 1990:291-298.
7. Fisher LA, Rivier J, Rivier C, Spiess J, Vale W, Brown MR: Corticotropin-releasing factor (CRF): Central effects on mean arterial pressure and heart rate in rats. Endocrinology 1982, 110:2222-2224.
8. LeFeuvre RA, Rothwell NJ, Stock MJ: Activation of brown fat thermogenesis in response to central injection of corticotropin releasing hormone in the rat. Neuropharmacology 1987, 26:1217-1221.
9. Taché Y, Gunion MM, Stephens R: CRF: Central nervous system action to influence gastrointestinal function and role in the gastrointestinal response to stress. In Corticotropin-releasing factor: Basic and clinical studies of a neuropeptide, Edited by De Souza EB, Nemeroff CB. Boca Raton; 1990:299-307.
10. Rivest S, Rivier C: The role of corticotropin-releasing factor and interleukin-1 in the regulation of neurons controlling reproductive functions. Endocrine Rev 1995, 16:177-199.
11. Koob GF, Britton KT: Behavioral effects of corticotropin-releasing factor. In Corticotropin-releasing factor: Basic and clinical studies of a neuropeptide, Edited by De Souza EB, Nemeroff CB. Boca Raton, FL: 1990:253-265.
12. Glowa JR, Barrett JE, Russell J, Gold PW: Effects of corticotropin releasing hormone on appetitive behaviors. Peptides 1992, 13:609-621
13. Rothwell NJ: Central effects of CRF on metabolism and energy balance. Neurosci Biobehav Rev 1990, 14:263-271.
14. Rivest S, Richard D: Involvement of corticotropin-releasing factor in the anorexia induced by exercise. Brain Res Bull 1990, 25:169-172.
15. Shibasaki T, Yamauchi N, Kato Y, Masuda A, Imaki T, Hotta M, Demura H, Oono H, Ling N, Shizume K: Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat. Life Sci 1988, 43:1103-1110.
16. Dagnault A, Ouerghi D, Richard D: Treatment with a-helical-CRF-(9-41) prevents the anorectic effect of 17-b-estradiol. Brain Res Bull 1993, 32:689-692.
17. Racotta IS, LeBlanc J, Richard D: The effect of caffeine on food intake in rats: involvement of corticotropin-releasing factor and the sympatho-adrenal system. Pharmacol Biochem Behav 1994, 48:887-892.
18. LeFeuvre RA, Aisenthal L, Rothwell NJ: Involvement of corticotropin-releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds. Brain Res 1991, 555:245-250.
19. Bovetto S, Rouillard C, Richard D: Role of CRH in the effects of 5-HT-receptor agonists on food intake and metabolic rate. Am J Physiol 1996, 271:R1231-R1238.
20. Cabanac M, Richard D: Acute intra-ventricular CRF lowers the hoarding threshold in male rats. Physiol Behav 1995, 57:705-710.
21. Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW: Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993, 133:3058-3061.
22. Lovenberg TM, Liaw CW, Grigoriadis DF, Clevenger W, Chalmers DT, Desouza EB, Olsterdorf T: Cloning and characterization of functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995, 92:836-840.
23. Kostich WA, Chen AR, Sperle K, Largent BL: Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: The CRF2 gamma receptor. Mol Endocrinol 1998, 12:1077-1085.
24. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W: Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 1994, 91:8777-8781.
25. Chalmers DT, Lovenberg TW, De Souza EB: Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 1995, 15:6340-6350.
26. Richard D, Rivest R, Naïmi N, Timofeeva E, Rivest S: Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology 1996, 137:4786-4795.
27. 2α-R within the ventromedial hypothalamic nucleus.
28. Smagin GN, Howell LA, Ryan DH, Desouza EB, Harris RBS: The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Neuroreport 1998, 9:1601-1606.
29. Arase K, Shargill MS, Bray GA: Effects of intraventricular infusion of corticotropin-releasing factor on VMH-lesioned obese rats. Am J Physiol 1989, 256:R751-R756.
30. Krahn DD, Gosnell BA, Levine AS, Morley JE: Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res 1988, 443:63-69.
31. Dagnault A, Richard D: Study of brain sites of CRF-estrogen interactions. Soc Neurosci Abs 1994, 20:589.
32. Egawa M, Yoshimatsu H, Bray GA: Preoptic area injection of corticotropin-releasing hormone stimulates sympathetic activity. Am J Physiol 1990, 259:R799-R806.
33. Rohner-Jeanrenaud F, Walker CD, Greco-Perotto R, Jeanrenaud B: Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 1989, 124:733-739.
34. Penicaud L, Cousin B, Leloup C, Atef N, Casteilla L, Ktorza A: Changes in autonomic nervous system activity and consecutive hyperinsulinaemia: respective roles in the development of obesity in rodents. Diabetes Metab 1996, 22:15-24.
35. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W: Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.
36. Donaldson, C.J., Sutto SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW: Cloning and characterization of human urocortin. Endocrinology 1996, 137:2167-2170.
37. Kozicz T, Yanaihara H, Arimura A: Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol 1998, 39:1-10.
38. LeFeuvre RA, Rothwell NJ, White A: A comparison of the thermogenic effects of CRF, sauvagine and urotansin I in the rat. Horm Metab Res 1989, 21:525-526.
39. Spina M, Merlo-Pich E, Chan RKW, Basso AM, Rivier J, Vale W, Koob GF: Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 1996, 273:1561-1564.
40. Jones DNC, Kortekaas R, Slade PD, Middlemiss DN, Hagan JJ: The behavioural effects of corticotropin releasing factor related peptides in rats. Psychopharmacology 1998, 138:124-132.
41. Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW: Cloning and Characterization of the cDNAs for Human and Rat Corticotropin Releasing Factor-Binding Proteins. Nature 1991, 349:423-426.
42. Behan DP, Heinrichs SC, Troncoso JC, Liu XJ, Kawas CH, Ling N, Desouza EB: Displacement of corticotropin-releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 1995, 378:284-287.
43. Heinrichs SC, Lapsansky J, Behan DP, Chan RKW, Sawchenko PE, Lorang M, Ling N, Vale WW, De Souza EB: Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Proc Natl Acad Sci USA 1996, 93:15475-15480. This study constitutes the first demonstration for the role of the CRH-binding protein in the regulation of energy balance.
44. Lovejoy DA, Aubry J-M, Turnbull A, Sutton S, Potter E, Yehling J, Rivier C, Vale WW: Ectopic expression of the CRF-binding protein: minor impact on HPA axis regulation but indication of sexually dimorphic weight gain. J Neuroendocrinol 1998, 10:483-491. This paper demonstrates that the overexpression of the CRH-binding protein can accelerate weight gain in female rats, providing further evidence for a role of the CRF binding protein in the regulation of energy balance.
45. Rivest S, Richard D: Hypothalamic paraventricular nucleus lesions do not prevent anorectic effect of exercise in male rats. Am J Physiol 1990, 259:R579-R584.
46. Dagnault A, Richard D: The lesion of the paraventricular nucleus of the hypothalamus does not prevent the effect of estradiol on energy balance. Am J Physiol 1993, 267:E32-E38.
47. Dieterich KD, Lehnert H, De Souza EB: Corticotropin-releasing factor receptors: an overview. Exp Clin Endocrinol Diabetes 1997, 105:65-82. This paper extensively reviewed the pharmacology and physiology of the CRH receptors.
48. Bovetto S, Richard D: Role of the central amygdaloid nuclei in the effects of exercise on energy balance in rats. Obesity Res 1993, 1:98S.
49. Plamondon H, Merali Z: Regulation of ingestion by CRF and bombesin-like peptides: Distinct meal-related peptide level changes. Am J Physiol Regul Integr C 1997, 41:R268-R274.
50. Champagne D, Beaulieu J, Drolet G: CRFergic innervation of the paraventricular nucleus of the rat hypothalamus: A tract-tracing study. J Neuroendocrinol 1998, 10:119-131. The authors of this paper have identified the site of origin of the CRH neurons projecting to the paraventricular hypothalamic nucleus. They demonstrated the existence of important projections emerging from the dorsomedial hypothalamic nucleus.
51. Tranchand-Bunet D, Delbende C, Guy J, Jegou S, Jenks BJ, Mocaer E, Pelletier G, Vaudry H: Les systèmes neuronaux a proopiomélanocortine. Rev Neurol 1987, 143:471-489.
52. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD: Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain Mol Endocrinol 1994, 8: 1298-1308.
53. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141. This paper emphasizes the importance of the melanocortin-4 receptor in the regulation of energy balance.
54. Rothwell NJ, Hardwick A, LeFeuvre RA, Crosby SR, White A: Central actions of CRF on thermogenesis are mediated by pro-opiomelanocortin products. Brain Res 1991, 541:89-92.
55. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D: Insulin in the brain-a hormonal regulator of energy balance. Endocrine Rev 1992, 13:387-414.
56. Rothwell NJ, Stock MJ: Insulin and thermogenesis. Int J Obes 1988, 12:93-102.
57. Friedman MI, Ramirez I: Food intake in diabetic rats: relationship to metabolic effects of insulin treatment. Physiol Behav 1994, 56:373-378.
58. Walker CD, Scribner KA, Stern JS, Dallman MF: Obese Zucker (fa/fa) rats exhibit normal target sensitivity to corticosterone and increased drive to adrenocorticotropin during the diurnal trough. Endocrinology 1992, 131:2629-2637.
59. Castonguay TW, Dallman MF, Stern JS: Some metabolic and behavioral effects of adrenalectomy on obese Zucker rats. Am J Physiol 1986, 251:R923-R933.
60. Galpin KS, Henderson RG, James WPT, Trayhurn P: GDP binding to brown-adipose-tissue mitochondria of mice treated chronically with corticosterone. Biochem J 1983, 214:265-268.
61. Romsos DR: Energy balance: role of adrenal gland secretions. In Proceedings of the 14th International congress of Nutrition, Edited by Young KW, Cha LY, Yull LK, Soon JJHe KS. Seoul; 1991:129-132.
62. Makino S, Gold PW, Schulkin J: Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 1994, 657:141-149.
63. Makino S, Gold PW, Schulkin J: Corticosterone effects on Corticotropin-Releasing hormone messenger RNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 1994, 640:105-112.
64. Sipols AJ, Baskin DG, Schwartz MW: Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 1995, 44:147-151.
65. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lellone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546.
66. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
67. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:540-543.
68. Levin N, Nelson C, Gurney A, Vandlen R, Desauvage F: Decreased food intake does not completely account for adipositry reduction after ob protein infusion. Proc Natl Acad Sci USA 1996, 93:1726-1730.
69. Arvaniti K, Ricquier D, Champigny O, Richard D: Leptin and corticosterone have opposite effects on food intake and the expression of UCP1 mRNA in brown adipose tissue of lepob/lepob mice. Endocrinology 1998, 139:4000-4004.
70. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B: Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998, 18:559-572. The authors of this study have identified neuropeptidergic neurons expressing the long form of the leptin receptor. They demonstrate that the CRH neurons expressed this receptor.
71. 12-41.
72. Uehara Y, Shimizu H, Ohtani K, Sato N, Mori M: Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes 1998, 47:890-893.
73. Huang O, Rivest R, Richard D: Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Endocrinology 1998, 139:1524-1532. This paper demonstrates the ability of leptin to prevent the neuronal activation of CRH neurons induced by food deprivation in the obese ob/ob mouse.
74. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS: Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997, 138:3859-3863. This paper demonstrates the ability of leptin to block CRH secretion from isolated rat hypothalami stimulated by glucose deprivation.
75. Ahima RS, Prabakaran D, Mantzoros C, Qu DQ, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 1996, 382:250-252.
76. Alemzadeh R, Jacobs W, Pitukcheewanont P: Antiobesity effect of diazoxide in obese Zucker rats. Metabolism 1996, 45:334-341.
77. Eghbal-Ahmadi M, Hatalski CG, Avishai-Eliner S, Baram TZ: Corticotropin releasing factor receptor type II (CRF2) messenger ribonucleic acid levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by maternal deprivation. Endocrinology 1997, 138:5048-5051.
78. Brady LS, Smith MA, Gold PW, Herkenham M: Altered expression of hypothalamic neuropeptide mRNAs in food restricted and food-deprived rats. Neuroendocrinology 1990, 52:441-447.
79. Plotsky PM, Thrivikraman KV, Watts AG, Hauger RL: Hypothalamic-pituitary-adrenal axis function in the Zucker obese rat. Endocrinology 1992, 130:1931-1941.
80. Williams G, McKibbin PE, McCarthy HD: Hypothalmic regulatory peptides and the regulation of food intake and energy balance-signals or noise. Proc Nutr Soc 1991, 50:527-544.
81. Billington CJ, Levine AS: Hypothalamic neuropeptide Y regulation of feeding and energy metabolism. Curr Opin Neurobiol 1992, 2:847-851.
82. Qu DQ, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek J, Kanarek R, Maratosflier E: A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996, 380:243-247.
83. Shutter JR, Graham M, Kinsey AC, Scully S, Lüthy R, Stark K: hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice. Gene Develop 1997, 11:593-602.
84. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S: Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998, 393:72-76.